期刊
HUMAN MOLECULAR GENETICS
卷 24, 期 19, 页码 5404-5415出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddv265
关键词
-
资金
- Australian National Health and Medical Research Council
- Australian Mitochondrial Disease Foundation (AMDF)
- Australian Research Council (ARC) [DP140102746]
- Victorian Government
- Deutsche Forschungsgemeinschaft
- Excellence Initiative of the German Federal Government [EXC 294 BIOSS]
- Excellence Initiative of the German State Government [EXC 294 BIOSS]
Biogenesis of complex IV of the mitochondrial respiratory chain requires assembly factors for subunit maturation, co-factor attachment and stabilization of intermediate assemblies. A pathogenic mutation in COA6, leading to substitution of a conserved tryptophan for a cysteine residue, results in a loss of complex IV activity and cardiomyopathy. Here, we demonstrate that the complex IV defect correlates with a severe loss in complex IV assembly in patient heart but not fibroblasts. Complete loss of COA6 activity using gene editing in HEK293T cells resulted in a profound growth defect due to complex IV deficiency, caused by impaired biogenesis of the copper-bound mitochondrial DNA-encoded subunit COX2 and subsequent accumulation of complex IV assembly intermediates. We show that the pathogenic mutation in COA6 does not affect its import into mitochondria but impairs its maturation and stability. Furthermore, we show that COA6 has the capacity to bind copper and can associate with newly translated COX2 and the mitochondrial copper chaperone SCO1. Our data reveal that COA6 is intricately involved in the copper-dependent biogenesis of COX2.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据